US FDA Could Use More Foreign Investigators If It Could Find Them, Woodcock Says
Executive Summary
Hiring travails, inspection pre-announcement, lack of translators highlighted in congressional hearing on FDA foreign inspections.
You may also be interested in...
GAO Advises US FDA On Inspection Pilot Plans; Notes Increased Oversight Of OAI Downgrades
As omicron COVID-19 variant recedes, GAO shares thoughts on FDA’s plans for unannounced foreign inspections and translation services pilots. The report also details agency efforts to fill vacant foreign inspection positions.
Senators Press For More Surprise Drug GMP Inspections Abroad
US FDA officials grilled during first Senate Finance Committee hearing in months over practice of preannouncing foreign inspections.
FDA Accelerates Inspection Process With New Concept Of Operations
'Concept of Operations' document spells out how FDA's realigned inspectorate and program offices will work together to accelerate drug manufacturing facility evaluations and inspections in line with generic and brand drug product reviews. Under the new approach, the agency expects to produce establishment inspection reports, facility classifications and warning letters more quickly, giving applicants more time to avoid manufacturing-related complete response letters.